» Articles » PMID: 30473750

Retrospective Analysis of Prognostic Factors in Patients of Papillary Thyroid Microcarcinoma

Overview
Journal Oncotarget
Specialty Oncology
Date 2018 Nov 27
PMID 30473750
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We performed a retrospective chart review of 245 patients with papillary thyroid microcarcinoma (PTMC) to define factors linked to central lymph node metastasis and thus prognosis. Univariate and multivariate analyses showed that being male ( < 0.001), age <45 years at diagnosis ( = 0.045), maximum tumor size > 5 mm ( = 0.030), multifocal tumor ( = 0.040) and tumor envelope invasion ( < 0.001) were all independent risk factors for central compartment lymph node metastasis. Unifocal lesions at the thyroid gland's upper pole, middle and lower pole, had lymph node metastasis rates of 22.7%, 14.0% and 35.0%, respectively ( = 0.048). The rate of central lymph node metastasis was much higher when there was bilateral thyroid involvement than with multifocal unilateral lesions (58.6% vs 37.5%; = 0.040). These results suggest that for patients at low risk of central lymph node metastasis, unilateral thyroid lobe and isthmus resection is sufficient. However, for patients at high risk of central lymph node metastasis, central lymph node dissection increases the likelihood of complete tumor excision.

Citing Articles

Predicting central lymph node metastasis in papillary thyroid carcinoma combined with Hashimoto's thyroiditis: a preoperative study.

Lou P, Huang Y, Li H, Zhao F, Xu J, Wang K BMC Cancer. 2025; 25(1):425.

PMID: 40065226 PMC: 11892260. DOI: 10.1186/s12885-025-13805-w.


Risk nomogram for papillary thyroid microcarcinoma with central lymph node metastasis and postoperative thyroid function follow-up.

Huang Y, Lou P, Li H, Li Y, Ma L, Wang K Front Endocrinol (Lausanne). 2024; 15:1395900.

PMID: 39530115 PMC: 11550994. DOI: 10.3389/fendo.2024.1395900.


A Nomogram Based on Clinicopathological and Ultrasound Imaging Characteristics for Predicting Cervical Lymph Node Metastasis in cN0 Unilateral Papillary Thyroid Microcarcinoma.

Zhang L, Ling Y, Zhao Y, Li K, Zhao J, Kang H Front Surg. 2021; 8:742328.

PMID: 34926565 PMC: 8677692. DOI: 10.3389/fsurg.2021.742328.


The Differences Between Multifocal and Unifocal Papillary Thyroid Carcinoma in Unilateral Lobe: A Meta-Analysis.

Zhang T, He L, Wang Z, Dong W, Sun W, Zhang P Front Oncol. 2021; 11:657237.

PMID: 34604025 PMC: 8483575. DOI: 10.3389/fonc.2021.657237.


Risk stratification of papillary thyroid microcarcinomas via an easy-to-use system based on tumor size and location: clinical and pathological correlations.

Szasz E, Nechifor-Boila A, Zahan A, Voidazan T, Borda A Rom J Morphol Embryol. 2021; 61(4):1153-1162.

PMID: 34171064 PMC: 8343526. DOI: 10.47162/RJME.61.4.17.


References
1.
Siddiqui S, White M, Antic T, Grogan R, Angelos P, Kaplan E . Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma. Thyroid. 2016; 26(6):807-15. DOI: 10.1089/thy.2015.0429. View

2.
Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L . Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery. 2006; 140(6):1000-5. DOI: 10.1016/j.surg.2006.08.001. View

3.
Lee Y, Shin S, Lim Y, Lee J, Wang S, Son S . Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer. Head Neck. 2013; 36(6):887-91. DOI: 10.1002/hed.23391. View

4.
Guo Y, Liu Z, Yu P, Liu C, Ming J, Zhang N . Using foci number to predict central lymph node metastases of papillary thyroid microcarcinomas with multifocality. Int J Clin Exp Med. 2015; 8(6):9925-30. PMC: 4538144. View

5.
Zhang L, Wei W, Ji Q, Zhu Y, Wang Z, Wang Y . Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab. 2012; 97(4):1250-7. DOI: 10.1210/jc.2011-1546. View